Drug Discovery Solutions

  1. Oligonucleotide CDMO: From Preclinical To Commercial 3/11/2026

    See how flexible synthesis platforms, structured CMC strategies, and advanced purification tools boost scalability, control impurities, and strengthen readiness for clinical and commercial oligo programs.

  2. A Fully Integrated Toolbox For Therapeutic Protein Expression

    The GS Xceed® Gene Expression System is a comprehensive toolbox for development of biologics that has been used to develop not only monoclonal antibodies but also a wide variety of new molecular formats.

  3. Accelerating CHO Bulk Harvest Testing Requires Rapid Methods 1/14/2026

    Reduce testing timelines from weeks to days with advanced viral detection, as well as achieve faster lot release and regulatory alignment while maintaining safety and compliance for CHO-based processes.

  4. SUREtechnology Platform™ 8/4/2023

    Explore how an advanced Cell Line Development (CLD) platform for new biologics can enable CHO-based cell line development; ensure premium, stable, and high-yield results; overcome common expression bottlenecks; and provide robust verification, genomic characterization, and monoclonality assessment services.

  5. TARGATT™ iPSC Kits 9/30/2025

    Build cell-based models of disease and accelerate therapeutic development with TARGATT™ large knock-in technology in iPSCs.

  6. iPSC Generation Services 9/30/2025

    iPSC generation is a complex process of reprogramming adult somatic cells into a pluripotent, embryonic stem cell-like stage.

  7. Cell Line Development 2/17/2022

    Our experience developing mammalian and microbial cell lines and our analytical capabilities enable us to identify and select clones that meet your product’s specific parameters and characteristics.

  8. ADCs: From Design To Development 1/4/2024

    Explore how a CDMO with specialized teams can support running different stages in parallel to facilitate data sharing and clear communication, ultimately taking your ADC from design to development.

  9. Discover Our iPSC Differentiated Cell Services 9/30/2025

    iPSC-differentiated cell lines combine scalability and biorelevance, enabling precise disease modeling, drug screening, and regenerative research with customizable lineage-specific differentiation options.

  10. Protein Degraders: From Discovery To Development 3/17/2026

    Leverage integrated platforms for targeted protein degradation and molecular glue solutions, from ligand identification to IND-enabling studies. Advanced screening and structural biology support accelerate discovery.